JMI LABS IS NOW PART OF LEARN MORE

Filter by Category: Medical Writing

Frequency of occurrence and daptomycin susceptibility rates of Gram-positive organisms causing bloodstream infections in cancer patients.

Frequency of occurrence and daptomycin susceptibility rates of Gram-positive organisms causing bloodstream infections in cancer patients. by Sader HS, Fritsche TR and Jones RN published in J. Chemother. 2008; 20 (5): 570-576

Serotype replacement and multiple resistance in Streptococcus pneumoniae after the introduction of the conjugate pneumonococcal vaccine.

Serotype replacement and multiple resistance in Streptococcus pneumoniae after the introduction of the conjugate pneumonococcal vaccine. by Mera R, Miller LA, Fritsche TR and Jones RN published in Microb. Drug Resist. 2008; 14 (2): 101-107

Antimicrobial activity of omiganan pentahydrochloride tested against contemporary bacterial pathogens commonly responsible for catheter-associated infections.

Antimicrobial activity of omiganan pentahydrochloride tested against contemporary bacterial pathogens commonly responsible for catheter-associated infections. by Fritsche TR, Rhomberg PR, Sader HS and Jones RN published in J. Antimicrob. Chemother. 2008; 61 (5): 1092-1098

First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States.

First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States. by Mendes RE, Deshpande LM, Castanheira M, DiPersio J, Saubolle MA and Jones RN published in Antimicrob. Agents Chemother. 2008; 52 (6): 2244-2246

Novel ß-lactams.

Novel ß-lactams. by Gales AC and Sader HS published in Braz. J. Infect. Dis. 2008; 12 (Suppl. 2): S46-S58

Complete sequence of p07-406, a 24,179-base-pair plasmid harboring the blaVIM-7 Metallo-ß-lactamase gene in a Pseudomonas aeruginosa isolates from the United States.

Complete sequence of p07-406, a 24,179-base-pair plasmid harboring the blaVIM-7 Metallo-ß-lactamase gene in a Pseudomonas aeruginosa isolates from the United States. by Li H, Toleman MA, Bennett PM, Jones RN and Walsh TR published in Antimicrob. Agents Chemother. 2008; 52 (9): 3099-3105

Use of pharmacodynamic endpoints for the evaluation of levofloxacin for the treatment of acute maxillary sinusitis.

Use of pharmacodynamic endpoints for the evaluation of levofloxacin for the treatment of acute maxillary sinusitis. by Ambrose PG, Anon JB, Bhavnani SM, Okusanya OO, Jones RN, Paglia MR, Kahn J and Drusano GL published in Diagn. Microbiol. Infect. Dis. 2008; 61 (1): 13-20

Proposed quality control ranges for 2-µg anidulafungin disk diffusion testing and ability of the method to detect strains with elevated echinocandin MIC values.

Proposed quality control ranges for 2-µg anidulafungin disk diffusion testing and ability of the method to detect strains with elevated echinocandin MIC values. by Jones RN, Ross JE and Sheehan DJ published in Diagnost Microbiol Infect Dis 2008; 62 (4): 474-477

Antimicrobial activity of DC-159a, a new fluroquinolone, against 1,149 recently collected clinical isolates.

Antimicrobial activity of DC-159a, a new fluroquinolone, against 1,149 recently collected clinical isolates. by Jones RN, Fritsche TR and Sader HS published in Antimicrob. Agents Chemother. 2008; 52 (10): 3763-3775

Zabofloxacin (DW-224a) activity against Neisseria gonorrhoeae including quinolone-resistant strains.

Zabofloxacin (DW-224a) activity against Neisseria gonorrhoeae including quinolone-resistant strains. by Jones RN, Biedenbach DJ, Ambrose PG and Wikler MA published in Diagn. Microbiol. Infect. Dis. 2008; 62 (1): 110-112

Key considerations in the treatment of complicated staphylococcal infections.

Key considerations in the treatment of complicated staphylococcal infections. by Jones RN published in Clin. Microbiol. Infect. 2008; 14 (Suppl 2): 3-9

Tigecycline activity tested against 11,808 bacterial pathogens recently collected from US medical centers.

Tigecycline activity tested against 11,808 bacterial pathogens recently collected from US medical centers. by Gales AC, Sader HS and Fritsche TR published in Diagn. Microbiol. Infect. Dis. 2008; 60 (4): 421-427

Antimicrobial susceptibility profile of contemporary clinical strains of Stenotrophomonas maltophilia isolates: Can moxifloxacin activity be predicted by levofloxacin MIC results?

Antimicrobial susceptibility profile of contemporary clinical strains of Stenotrophomonas maltophilia isolates: Can moxifloxacin activity be predicted by levofloxacin MIC results?. by Gales AC, Jones RN and Sader HS published in J. Chemother. 2008; 20 (1): 38-42

Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-beta-lactamase in Spain: Toward endemicity?

Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-beta-lactamase in Spain: Toward endemicity? by Tato M, Coque TM, Ruiz-Garbajosa P, Pintado V, Cobo J, Sader HS, Jones RN, Baquero F and Canton R published in Clin. Infect. Dis. 2007; 45 (9): 1171-1178

Serial sinus aspirate samples during high-dose, short course levofloxacin treatment of acute maxillary sinusitis.

Serial sinus aspirate samples during high-dose, short course levofloxacin treatment of acute maxillary sinusitis. by Anon JB, Paglia M, Xiang J, Ambrose PG, Jones RN and Kahn JB published in Diagn. Microbiol. Infect. Dis. 2007; 57 (1): 105-107

Comparison of the probability of target attainment between ceftriaxone and cefepime in the cerebrospinal fluid and serum against Streptococcus pneumoniae.

Comparison of the probability of target attainment between ceftriaxone and cefepime in the cerebrospinal fluid and serum against Streptococcus pneumoniae. by Lodise TP, Nau R, Kinzig M, Jones RN, Drusano GL and Sorgel F published in Diagn. Microbiol. Infect. Dis. 2007; 58 (4): 445-452

Development of anidulafungin for disk diffusion susceptibility testing against Candida spp.

Development of anidulafungin for disk diffusion susceptibility testing against Candida spp. by Jones RN, Kirby JT, Messer SA and Sheehan DJ published in Diagn. Microbiol. Infect. Dis. 2007; 58 (3): 371-374

Tigecycline disk diffusion breakpoints of Acinetobacter spp.: A clinical point of view.

Tigecycline disk diffusion breakpoints of Acinetobacter spp.: A clinical point of view. by Curcio D, Fernandez F, Jones RN, Ferraro MJ, Reller LB, Schreckenberger PC and Sader HS published in J. Clin. Microbiol. 2007; 45 (6): 2095-2096

Comment on: Occurrence prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals.

Comment on: Occurrence prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals. by Walsh TR, Toleman MA and Jones RN published in J. Antimicrob. Chemother. 2007; 59 (4): 799-800

Accuracies of beta-lactam susceptibility test results for Pseudomonas aeruginosa with four automated systems (BD Phoenix, MicroScan WalkAway, Vitek and Vitek 2).

Accuracies of beta-lactam susceptibility test results for Pseudomonas aeruginosa with four automated systems (BD Phoenix, MicroScan WalkAway, Vitek and Vitek 2). by Juretschko S, LaBombardi VJ, Lerner SA and Schreckenberger PC published in J. Clin. Microbiol. 2007; 45 (4): 1339-1342

Influence of polysorbate-80 when determining the tigecycline MIC by the reference method.

Influence of polysorbate-80 when determining the tigecycline MIC by the reference method. by Jones RN, Knapp CC and Dowzicky MJ published in Diagn. Microbiol. Infect. Dis. 2007; 58 (1): 145-146

Activity of garenoxacin, an investigational des-F(6)-quinolone, tested against pathogens from community-acquired respiratory tract infections, including those with elevated or resistant-level fluoroquinolone MIC values.

Activity of garenoxacin, an investigational des-F(6)-quinolone, tested against pathogens from community-acquired respiratory tract infections, including those with elevated or resistant-level fluoroquinolone MIC values. by Jones RN, Fritsche TR, Sader HS and Stilwell MG published in Diagn. Microbiol. Infect. Dis. 2007; 58 (1): 9-17

Reevaluation of Clinical and Laboratory Standards Institute disk diffusion breakpoints for tetracyclines for testing Enterobacteriaceae.

Reevaluation of Clinical and Laboratory Standards Institute disk diffusion breakpoints for tetracyclines for testing Enterobacteriaceae. by Sader HS, Ferraro MJ, Reller LB, Schreckenberger PC, Swenson JM and Jones RN published in J. Clin. Microbiol. 2007; 45 (5): 1640-1643

Oral β-lactams applied to uncomplicated infections of skin and skin structures.

Oral β-lactams applied to uncomplicated infections of skin and skin structures. by Jacobs MR, Jones RN and Giordano PA published in Diagn. Microbiol. Infect. Dis. 2007; 57 (Suppl 3): 55S-65S

Detection of inducible clindamycin resistance in staphylcococi by broth microdilution using erythromycin-clindamycin combination wells.

Detection of inducible clindamycin resistance in staphylcococi by broth microdilution using erythromycin-clindamycin combination wells. by Swenson JM, Brasso WB, Ferraro MJ, Hardy DJ, Knapp CC, McDougal LK, Reller LB, Sader HS, Shortridge D, Skov R, Weinstein MP, Zimmer BL and Patel JB published in J. Clin. Microbiol. 2007; 45 (12): 3954-3957

Activity of dalbavancin tested against Staphylococcus spp. and β-haemolytic Staphylococcus spp. isolated from 52 geographically diverse medical centers in the United States.

Activity of dalbavancin tested against Staphylococcus spp. and β-haemolytic Staphylococcus spp. isolated from 52 geographically diverse medical centers in the United States. by Biedenbach DJ, Ross JE, Fritsche TR, Sader HS and Jones RN published in J. Clin. Microbiol. 2007; 45 (3): 998-1004

Review of the spectrum and potency of orally administered cephalosporins and amoxicillin/clavulanate.

Review of the spectrum and potency of orally administered cephalosporins and amoxicillin/clavulanate. by Sader HS, Jacobs MR and Fritsche TR published in Diagn. Microbiol. Infect. Dis. 2007; 57 (Suppl 3): 5S-12S

Bactericidal activity of cefepime and ceftriaxone tested against Streptococcus pneumoniae.

Bactericidal activity of cefepime and ceftriaxone tested against Streptococcus pneumoniae. by Pottumarthy S, Sader HS and Jones RN published in Diagn. Microbiol. Infect. Dis. 2007; 57 (3): 345-349

The role of newer orally administered cephalosporins in contemporary outpatient practice.

The role of newer orally administered cephalosporins in contemporary outpatient practice. by Hadley JA and Fritsche TR published in Diagn. Microbiol. Infect. Dis. 2007; 57 (3 Suppl): 1S-3S

Tigecycline (GAR-936) activity against Streptococcus gallolyticus (bovis) and viridans group streptococci.

Tigecycline (GAR-936) activity against Streptococcus gallolyticus (bovis) and viridans group streptococci. by Moet GJ, Dowzicky MJ and Jones RN published in Diagn. Microbiol. Infect. Dis. 2007; 57 (3): 333-336

Agar dilution and disk diffusion susceptibility testing of Campylobacter spp.

Agar dilution and disk diffusion susceptibility testing of Campylobacter spp. by Fritsche TR, McDermott PF, Shryock TR and Walker RD published in J. Clin. Microbiol. 2007; 45: 2758-2759

Oxazolidinone susceptibility patterns for 2005: International report from the Zyvox® Annual Appraisal of Potency and Spectrum Study.

Oxazolidinone susceptibility patterns for 2005: International report from the Zyvox®; Annual Appraisal of Potency and Spectrum Study. by Ross JE, Fritsche TR, Sader HS and Jones RN published in Int. J. Antimicrob. Agents 2007; 29 (3): 295-301

Selection of a surrogate beta-lactam testing agent for initial susceptibility testing of doripenem, a new carbapenem.

Selection of a surrogate beta-lactam testing agent for initial susceptibility testing of doripenem, a new carbapenem. by Jones RN, Sader HS, Fritsche TR and Janechek MJ published in Diagn. Microbiol. Infect. Dis. 2007; 59 (4): 467-472

Cefdinir: An oral cephalosporin for the treatment of respiratory tract infections and skin and skin structure infections.

Cefdinir: An oral cephalosporin for the treatment of respiratory tract infections and skin and skin structure infections. by Sader HS and Jones RN published in Expert Rev. Anti. Infect. Ther. 2007; 5 (1): 29-43

Factors influencing broth microdilution antimicrobial susceptibility test results for dalbavancin, a new glycopeptide agent.

Factors influencing broth microdilution antimicrobial susceptibility test results for dalbavancin, a new glycopeptide agent. by Rennie RP, Koeth L, Jones RN, Fritsche TR, Knapp CC, Killian SB and Goldstein BP published in J. Clin. Microbiol. 2007; 45 (10): 3151-3154

Multicenter studies of tigecycline disk diffusions susceptibility results for Acinetobacter spp.

Multicenter studies of tigecycline disk diffusions susceptibility results for Acinetobacter spp. by Jones RN, Ferraro MJ, Reller LB, Schreckenberger PC, Swenson JM and Sader HS published in J. Clin. Microbiol. 2007; 45 (1): 227-230

Update on the cefdinir spectrum and potency against pathogens isolated from uncomplicated skin and soft tissue infections in North America: Are we evaluating the orally administered cephalosporins correctly?

Update on the cefdinir spectrum and potency against pathogens isolated from uncomplicated skin and soft tissue infections in North America: Are we evaluating the orally administered cephalosporins correctly? by Jones RN and Sader HS published in Diagn. Microbiol. Infect. Dis. 2006; 55 (4): 351-356

Comment on: Linezolid resistance in coagulase-negative staphylococci.

Comment on: Linezolid resistance in coagulase-negative staphylococci. by Jones RN, Ross JE, Fritsche TR and Sader HS published in J. Antimicrob. Chemother. 2006; 58 (4): 899-900

Emergence of linezolid-resistant Staphylococcus aureus during treatment of pulmonary infection in a patient with cystic fibrosis.

Emergence of linezolid-resistant Staphylococcus aureus during treatment of pulmonary infection in a patient with cystic fibrosis. by Gales AC, Sader HS, Andrade SS, Lutz L, Machado A and Barth AL published in Int. J. Antimicrob. Agents 2006; 27 (4): 300-302

Microbiological features of vancomycin in the 21st Century: Minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains.

Microbiological features of vancomycin in the 21st Century: Minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains. by Jones RN published in Clin. Infect. Dis. 2006; 42 (Suppl 1): S13-S24

Susceptibility to amoxycillin-clavulanate among clinical isolates of Escherichia coli resistant to cefoxitin.

Susceptibility to amoxycillin-clavulanate among clinical isolates of Escherichia coli resistant to cefoxitin. by Fernandez-Cuenca F, Martinez-Martinez L, Amblar G, Biedenbach DJ, Jones RN and Pascual A published in Clin. Microbiol. Infect. 2006; 12 (2): 197-198

The activity of daptomycin against wildtype Staphylococcus aureus and strains with reduced susceptibility to vancomycin.

The activity of daptomycin against wildtype Staphylococcus aureus and strains with reduced susceptibility to vancomycin. by Sader HS and Jones RN published in Clin. Infect. Dis. 2006; 43 (6): 798-799

Accuracy of three automated systems (MicroScan WalkAway, VITEK, and VITEK 2) for susceptibility testing of Pseudomonas aeruginosa against five broad-spectrum β-lactam agents.

Accuracy of three automated systems (MicroScan WalkAway, VITEK, and VITEK 2) for susceptibility testing of Pseudomonas aeruginosa against five broad-spectrum β-lactam agents. by Sader HS, Fritsche TR and Jones RN published in J. Clin. Microbiol. 2006; 44 (3): 1101-1104

Performance accuracy of antibacterial and antifungal susceptibility test methods: Report from the College of American Pathologists Microbiology Surveys Program (2001-2003).

Performance accuracy of antibacterial and antifungal susceptibility test methods: Report from the College of American Pathologists Microbiology Surveys Program (2001-2003). by Pfaller MA and Jones RN published in Arch. Pathol. Lab. Med. 2006; 130 (6): 767-778

Activity of gemifloxacin tested against Neisseria gonorrhoeae isolates including antimicrobial-resistant phenotypes.

Activity of gemifloxacin tested against Neisseria gonorrhoeae isolates including antimicrobial-resistant phenotypes. by Pottumarthy S, Fritsche TR and Jones RN published in Diagn. Microbiol. Infect. Dis. 2006; 54 (2): 127-134

Comparison of dalbavancin MIC values determined by Etest (AB BIODISK) and reference dilution methods using Gram-positive organisms.

Comparison of dalbavancin MIC values determined by Etest (AB BIODISK) and reference dilution methods using Gram-positive organisms. by Fritsche TR, Rennie RP, Goldstein BP and Jones RN published in J. Clin. Microbiol. 2006; 44 (8): 2988-2990

Health and economic outcomes of the detection of Klebsiella pneumoniae-produced extended-spectrum β-lactamase (ESBL) in a hospital with high prevalence of this infection.

Health and economic outcomes of the detection of Klebsiella pneumoniae-produced extended-spectrum β-lactamase (ESBL) in a hospital with high prevalence of this infection. by Marra AR, Pereira CA, Castelo A, do Carmo Filho JR, Cal RG, Sader HS and Wey SB published in Int. J. Infect. Dis. 2006; 10 (1): 56-60

Activity of DX-619 compared to other agents against viridians group streptococci, Streptococcus bovis, and Cardiobacterium hominis.

Activity of DX-619 compared to other agents against viridians group streptococci, Streptococcus bovis, and Cardiobacterium hominis. by Kosowska-Shick K, Smith K, Bogdanovich T, Ednie LM, Jones RN and Appelbaum PC published in Antimicrob. Agents Chemother. 2006; 50 (12): 4191-4194

Comparison of censored regression and standard regression analyses for modeling relationships between antimicrobial susceptibility and patient- and institution-specific variables.

Comparison of censored regression and standard regression analyses for modeling relationships between antimicrobial susceptibility and patient- and institution-specific variables. by Hammel JP, Bhavnani SM, Jones RN, Forrest A, Ambrose PG published in Antimicrob. Agents Chemother. 2006; 50 (1): 62-67

Pharmacodynamics of cefprozil against Haemophilus influenzae in an in vitro pharmacodynamic model.

Pharmacodynamics of cefprozil against Haemophilus influenzae in an in vitro pharmacodynamic model. by Smith PF, Tsuji B, Booker BM, Forrest A, Bajic S, Kelchlin P, Bhavnani SM, Jones RN and Ambrose PG published in Diagn. Microbiol. Infect. Dis. 2006; 56 (4): 379-386